Pujan Ajmera
ajmera-pujan.bsky.social
Pujan Ajmera
@ajmera-pujan.bsky.social
Ph.D. Candidate in Theoretical and Computational Chemistry @ UCLA

Huge fan of understanding non-trivial quantum mechanic effects in biological systems
Reposted by Pujan Ajmera
We conducted a #ChemNobel prediction poll in the group on the #NobelPrize in Chemistry Eve!

(PS: we might be a little biased 😉) #chemsky #compchem #compchemsky
October 8, 2025 at 3:14 AM
Reposted by Pujan Ajmera
✨Exciting news - the Alexandrova Group is now on Bluesky!✨

Hello, friends on #chemsky and #compchemsky. We're glad to be here! Stay tuned for the latest #compchem 💻 research and news from the lab!
October 3, 2025 at 10:45 PM
Reposted by Pujan Ajmera
ORCA 6.1 will be released tomorrow after the online event to which you are all invited! As a final appetiser, we have a sneak preview of some new methods that will be available in the new version.

#ORCA61 #ORCAqc #CompChem #QuantumChem #TheoChem #FACCTs #MPIKOFO #ChemSky #CompChemSky
June 16, 2025 at 11:03 AM
Reposted by Pujan Ajmera
shel silverstein on the LLM, 1981
June 10, 2025 at 7:34 PM
Reposted by Pujan Ajmera
🧪In a JAMA viewpoint paper, the FDA expresses its intent to use AI for first-pass reviews of drug applications to significantly increase efficiency.

This is premature and we haven't seen the evidence AI is ready for this use case.

Link to the paper: jamanetwork.com/journals/jam...

#MedSky #MLSky
F.D.A. to Use A.I. in Drug Approvals to ‘Radically Increase Efficiency’
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
www.nytimes.com
June 10, 2025 at 9:11 PM